Nanosuspension technology and its applications in drug delivery

被引:52
作者
Arunkumar, N. [1 ]
Deecaraman, M. [1 ]
Rani, C. [2 ]
机构
[1] Dr MGR Univ, Dept Ind Biotechnol, Madras 600095, Tamil Nadu, India
[2] Cherraans Coll Pharm, Dept Pharmaceut, Coimbatore 641039, Tamil Nadu, India
关键词
Dissolution; nanosuspension; solubility enhancement; saturation solubility;
D O I
10.4103/0973-8398.56293
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Solubility is an essential factor for drug effectiveness, independent of the route of administration. Poorly soluble drugs are often a challenging task for formulators in the industry. Conventional approaches for enhancement of solubility have limited applicability, especially when the drugs are poorly soluble simultaneously in aqueous and in non-aqueous media. Nanosuspension technology can be used to improve the stability as well as the bioavailability of poorly soluble drugs. Nanosuspensions are biphasic systems consisting of pure drug particles dispersed in an aqueous vehicle, stabilized by surfactants. These are simple to prepare and are more advantageous than other approaches. Techniques such as wet milling, high-pressure homogenization, emulsification-solvent evaporation and super critical fluid have been used in the preparation of nanosuspensions. It has the advantage of delivery by various routes, including oral, parenteral, pulmonary and ocular routes. The present article reviews the current methods used to prepare nanosuspensions and their application in drug delivery.
引用
收藏
页码:168 / 173
页数:6
相关论文
共 33 条
  • [1] Abu T. M., 2000, J PHARM SCI, V88, P1058
  • [2] Lab-scale production unit design for nanosuspensions of sparingly soluble cytotoxic drugs
    Böhm, BHL
    Müller, RH
    [J]. PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1999, 2 (08): : 336 - 339
  • [3] Production of griseofulvin nanoparticles using supercritical CO2 antisolvent with enhanced mass transfer
    Chattopadhyay, P
    Gupta, RB
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 228 (1-2) : 19 - 31
  • [4] Oleanolic acid nanosuspensions: preparation, in-vitro characterization and enhanced hepatoprotective effect
    Chen, YJ
    Liu, J
    Yang, XL
    Zhao, XL
    Xu, HB
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 (02) : 259 - 264
  • [5] Clewlow P., 2004, SCRIPS TARGET WORLD, V35, P316
  • [6] DEARN AR, 2000, Patent No. 6018080
  • [7] Dubey R, 2006, DRUG DELIV TECHNOL, V6, P65
  • [8] Fromming KH, 1998, PHARMAZEUTISCHE TECH
  • [9] Production and characterization of a budesonide nanosuspension for pulmonary administration
    Jacobs, C
    Müller, RH
    [J]. PHARMACEUTICAL RESEARCH, 2002, 19 (02) : 189 - 194
  • [10] Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide
    Jacobs, C
    Kayser, O
    Müller, RH
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 196 (02) : 161 - 164